Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Univ Svizzera Italiana USI, Euler Inst, Fac Biomed Sci, Lugano, Switzerland..ORCID iD: 0000-0002-5440-6167
Univ Delaware, Dept Phys & Astron, Newark, DE USA.;Univ Delaware, Dept Chem & Biochem, Newark, DE USA..
Univ Oxford, Dept Biochem, Oxford, England..ORCID iD: 0000-0001-6360-7959
Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Leipzig, Germany..
Show others and affiliations
2025 (English)In: Nature reviews. Drug discovery, ISSN 1474-1776, E-ISSN 1474-1784, Vol. 24, no 4, p. 251-275Article, review/survey (Refereed) Published
Abstract [en]

G protein-coupled receptors (GPCRs) are the largest human membrane protein family that transduce extracellular signals into cellular responses. They are major pharmacological targets, with approximately 26% of marketed drugs targeting GPCRs, primarily at their orthosteric binding site. Despite their prominence, predicting the pharmacological effects of novel GPCR-targeting drugs remains challenging due to the complex functional dynamics of these receptors. Recent advances in X-ray crystallography, cryo-electron microscopy, spectroscopic techniques and molecular simulations have enhanced our understanding of receptor conformational dynamics and ligand interactions with GPCRs. These developments have revealed novel ligand-binding modes, mechanisms of action and druggable pockets. In this Review, we highlight such aspects for recently discovered small-molecule drugs and drug candidates targeting GPCRs, focusing on three categories: allosteric modulators, biased ligands, and bivalent and bitopic compounds. Although studies so far have largely been retrospective, integrating structural data on ligand-induced receptor functional dynamics into the drug discovery pipeline has the potential to guide the identification of drug candidates with specific abilities to modulate GPCR interactions with intracellular effector proteins such as G proteins and β-arrestins, enabling more tailored selectivity and efficacy profiles.

Place, publisher, year, edition, pages
Springer Nature, 2025. Vol. 24, no 4, p. 251-275
National Category
Pharmacology and Toxicology Cell and Molecular Biology Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-558405DOI: 10.1038/s41573-024-01083-3ISI: 001388173700001PubMedID: 39747671Scopus ID: 2-s2.0-85213837901OAI: oai:DiVA.org:uu-558405DiVA, id: diva2:1965758
Funder
EU, European Research Council, 101001784Available from: 2025-06-09 Created: 2025-06-09 Last updated: 2025-06-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Gutiérrez-de-Terán, Hugo

Search in DiVA

By author/editor
Conflitti, PaoloSansom, Mark S. P.Gutiérrez-de-Terán, HugoYuan, ShuguangBarth, PatrickRobinson, Anne S.Limongelli, Vittorio
By organisation
Computational Biology and Bioinformatics
In the same journal
Nature reviews. Drug discovery
Pharmacology and ToxicologyCell and Molecular BiologyPharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 232 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf